Trump says he’s not positive US must be spending something on NATO


By Trevor Hunnicutt

WASHINGTON (Reuters) -U.S. President Donald Trump on Thursday stated he was unsure america must be spending something on NATO, telling reporters the U.S. was defending NATO members, however they have been “not defending us.”

Trump earlier demanded that different members of the transatlantic alliance spend 5% of their gross home product (GDP) on protection – an enormous improve from the present 2% purpose and a stage that no NATO nation, together with america, at the moment achieves.

“I am unsure we must be spending something, however we should always actually be serving to them,” Trump advised reporters after signing an government order within the Oval Workplace. “We’re defending them. They don’t seem to be defending us.”

“They need to up their 2% to five%,” he stated, repeating his remarks earlier to the World Financial Discussion board in Davos, Switzerland.

admin

Share
Published by
admin

Recent Posts

US exit from Paris local weather deal complicates finance targets, says COP30 head

BRASILIA (Reuters) -Brazil sees a possibility to amplify the voices of growing nations in upcoming…

4 minutes ago

Unique-Activist Ananym plans to launch proxy combat at Henry Schein, sources say

By Svea Herbst-Bayliss NEW YORK (Reuters) - Activist investor Ananym Capital Administration plans to appoint…

14 minutes ago

Former CEO of Binance says US Strategic Bitcoin Reserve ‘just about confirmed”

Investing.com -- The prospect of a U.S. Strategic Bitcoin Reserve seems to be gaining traction, with…

24 minutes ago

Buckle Inc CEO sells shares value over $989k

Dennis H. Nelson, President and CEO of Buckle Inc. (NYSE:BKE), lately reported promoting a big…

29 minutes ago

Columbia Banking System beats This autumn earnings estimates, income barely misses

TACOMA, Wash. - Columbia Banking System, Inc. (NASDAQ: NASDAQ:COLB) reported fourth quarter 2024 earnings that…

39 minutes ago

Ultragenyx’s SWOT evaluation: uncommon illness inventory poised for development

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), presently valued at $3.97 billion, has positioned itself as a key…

44 minutes ago